Recombinant Anti-CD38 x Anti-CD59 Bispecific Antibody (scIgG) is designed to be expressed as two chains, each chain has the same units with their parental IgG antibodies, anti-CD38 and anti-CD59 IgGs. The two chains form heterodimer via Fc KIH technology. This BsAb can recruit complement to tumor cells. It is designed for the research of Multiple myeloma (MM); Hematologic malignancies therapy.
Welcome! For price inquiries, we will get back to you as soon as possible.
INQUIRY